WHO urges bilateral deals as Mpox vaccines remain scarce worldwide
By: Rebecca Okine
The World Health Organization (WHO) has confirmed that vaccines for Mpox are currently in limited global supply, posing a challenge to countries like Ghana where new cases continue to rise.
Speaking to the media, WHO Country Preparedness and IHR Officer Sally-Ann Ohene explained that while some nations have secured access to Mpox vaccines, many others, including Ghana, are facing shortages.
“For Mpox, vaccines are in very short supply. They are not readily available. Some countries have them, but globally, there are not enough,” she said.
She added that the WHO is encouraging affected countries to seek vaccines through bilateral arrangements. “We are promoting bilateral engagement with countries that have vaccines so others can access some doses while global advocacy for increased production continues,” Ms. Ohene stated.
This information comes as the Ghana Health Service (GHS) confirmed 34 new Mpox cases as of Tuesday, June 10, 2025, bringing the total number of cases to 79. The virus has now spread across 10 regions, with four patients currently admitted and under close observation. Contact tracing is underway to contain further spread.
In a statement, the GHS urged the public to remain calm, assuring that the situation is under control.
Mpox, formerly known as monkeypox, is a viral disease similar to smallpox and spreads primarily through close physical contact.
Dr. Ohene also emphasized the importance of prevention in the face of vaccine shortages.
“We need to take personal responsibility, especially with hand hygiene, something we learned during COVID but have sadly neglected,” she said.
She advised the public to wash hands regularly with soap under running water and avoid close contact with individuals showing signs of rashes. She added that suspected cases should be isolated at home and seek immediate medical testing. “Mpox can resemble other illnesses, so early testing and avoiding close contact are key,” she added.
